If in fact future studies robustly establish a beneficial effect of the drug class in HF, it may allow for broader adoption of GLP-1 RAs in the prevalent CVD, ultimately contributing to addressing the unmet medical need that continues to persist in the prevention or management of, in particular, HFpEF
In: Erdman JWJ, Macdonald IA, Zeisel SH, eds
About 30 to 40 percent of commercial plans cover Wegovy or Zepbound for obesity, usually with prior authorization requirements (BMI thresholds, documented diet and exercise attempts, sometimes step therapy)
In this article If you have Hashimotos thyroiditis or hypothyroidism, you may be tempted to reach for supplements that promise to boost energy, balance hormones, or even heal your thyroid
Excluding GLP-1s from your Rx plan does not mean youre avoiding the cost
Many people wonder whether they should take glutathione in pill form, get a shot, or opt for the IV drip